Pandemic ‘Dividend’ Must Not Be Squandered

Diagnostics Companies Press For Higher Priority Status For Data Sharing And Access To Testing

Maintaining the positive changes that health care delivery underwent at the height of COVID-19 has been the talk of the health care industries, but will commercial organizations retain their enthusiasm once the pressures of the pandemic abate?

Light bulb idea.

More from Leadership

More from Medtech Insight